- For US Healthcare Providers
- Full Prescribing Information
REQUEST INFORMATION
WHAT IS SIMPONI ARIA® (golimumab)?
SIMPONI ARIA® is the only fully human anti-TNF IV biologic therapy without a biosimilar—ready to fight the symptoms of RA, PsA, and AS with:
- Proven efficacy in moderately to severely active RA, active PsA, and active AS
- Demonstrated safety
-
An infusion experience you can control
-
An efficient 30-minute infusion given at Weeks 0 and 4, then every 8 weeks thereafter—as few as 6 times a year
- "Efficient" is defined as the total amount of time required to infuse
- Weight-based dosing (2 mg/kg)2
- No reconstitution required2
-
An efficient 30-minute infusion given at Weeks 0 and 4, then every 8 weeks thereafter—as few as 6 times a year
-
Prescribing control for you, affordability support for your patients
- The only IV anti-TNF therapy without a biosimilar
- First-line biologic access for commercially insured patients
- Co-pay support
- Janssen CarePath
- Contract Purchase Program